Glenview Capital Management’s CVS Health CVS Stock Holding History

Glenview Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$499M	Sell	4,824,799 -3,372,000	-41%	-$301M	9.09%	2
2026 Q1	$589M	Hold	8,196,799	–	–	14.78%	1
2025 Q4	$650M	Hold	8,196,799	–	–	13.24%	1
2025 Q3	$618M	Hold	8,196,799	–	–	13.76%	1
2025 Q2	$565M	Sell	8,196,799 -3,750,000	-31%	-$246M	15.84%	1
2025 Q1	$809M	Hold	11,946,799	–	–	19.9%	1
2024 Q4	$536M	Hold	11,946,799	–	–	13.56%	1
2024 Q3	$751M	Buy	11,946,799 +2,784,410	+30%	+$162M	14.53%	1
2024 Q2	$541M	Buy	9,162,389 +7,465,959	+440%	+$467M	10.65%	2
2024 Q1	$135M	Buy	1,696,430 +950,286	+127%	+$72.6M	2.37%	14
2023 Q4	$58.9M	Buy	+746,144	New	+$53.1M	1.26%	22
2019 Q1	–	Sell	-8,489,991	Closed	-$556M	–	51
2018 Q4	$556M	Buy	8,489,991 +1,875,037	+28%	+$140M	5.39%	5
2018 Q3	$521M	Buy	6,614,954 +1,192,714	+22%	+$85.3M	3.31%	11
2018 Q2	$349M	Sell	5,422,240 -2,372,148	-30%	-$156M	2.38%	18
2018 Q1	$485M	Buy	7,794,388 +972,757	+14%	+$69.8M	2.84%	13
2017 Q4	$495M	Buy	6,821,631 +5,452,628	+398%	+$396M	2.67%	17
2017 Q3	$111M	Buy	+1,369,003	New	+$108M	0.65%	39

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Glenview Capital Management's CVS Position: Q2 2026 in Review

Glenview Capital Management reduced its CVS Health (CVS) stake by 41% in Q2 2026, selling an estimated $301M and leaving 4,824,799 shares worth $499M. The position accounts for 9.09% of the portfolio, ranked #2.

Glenview Capital Management first reported a position in CVS in Q3 2017 and has held it in 17 quarters since. The position peaked at $809M in Q1 2025. 2,064 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Glenview Capital Management held 4,824,799 shares of CVS Health worth $499M as of Q2 2026.
Glenview Capital Management sold 3,372,000 CVS Health shares in Q2 2026, an estimated $301M.
CVS Health made up 9.09% of Glenview Capital Management's portfolio in Q2 2026, its #2 holding.
Glenview Capital Management first reported a position in CVS Health in Q3 2017 and has held it in 17 quarters since.
Glenview Capital Management's CVS Health position peaked at $809M in Q1 2025.
2,064 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Glenview Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.